Work

Abstract PS1-11-11: Outcomes in patients with PIK3CA-mutated breast cancer treated with metformin

Year: 2026

Type: conference-abstract

Source: Clinical Cancer Research

DOI: 10.1158/1557-3265.sabcs25-ps1-11-11

Authors: C. Travaline, R. Plagens, A. Elliott, G. Sledge, J. Hundal, J. P. Leone, S. L. Graff, M. Lustberg, M. Vasekar

Institutions: Pennsylvania State University, Penn State Milton S. Hershey Medical Center, Caris Life Sciences (United States), Cleveland Clinic, Dana-Farber Cancer Institute, Brown University, Lifespan, Yale University, Smilow Cancer Hospital

Language: English

Topic: Metabolism, Diabetes, and Cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7129382226

Cites:

Cited by:

Related to: